Welcome to our online resources library


Perigord promote a culture of quality, operational excellence and GMP compliant processes. These documents share some of our experience in managing artwork through the artwork lifecycle process, and what we believe is critical in ensuring excellence. We hope you will find these resources helpful.

Articles


By Adriana Medina 06 Nov, 2023
Whitepaper zur Auswahl eines strategischen Partners für die Auslagerung von Artwork und Labelling in der D‑A‑CH-Region Wertsteigerung und Risikominderung durch Auslagerung an ein Fachunternehmen – ein Whitepaper zu bewährten Verfahren
12 May, 2022
Advanced Artwork and Labelling Production Analytics White Paper Pharmaceutical Artwork Departments can accelerate business impact with Advanced Artwork and Labelling Production Analytics (AALPA)
11 May, 2022
Selecting a Strategic Outsourcing Artwork and Labelling Partner White Paper Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper
06 Oct, 2020
Due to COVID-19, auditing as we know it is changing. In-person audits are increasingly being replaced by remote audits. Read our guide to a successful remote audit.
By Gary Orr 16 Jul, 2019
Your company celebration and kudos does not last long as someone spots an artwork issue. In other words: here comes the recall. Yes, the worst-case scenario. We guess you won't sleep very well until this nightmare is over. If you are looking for fully compliant and error-free pharma artworks to hit the market efficiently while reducing your stress levels, keep an eye on the following four most common pharma artwork hurdles: One: Artwork process problems: Outdated and inefficient manual systems, systematic errors, inconsistencies, process gaps... all of them will develop into artwork errors. Too many assets, too many emails, too many people. Two: Compliance burdens: Labelling needs to be compliant with local regulations and current Good Manufacturing Practice, and this is probably the biggest concern for pharma companies. As these two become more and more complex over time, we need to ensure not only our company is fully aligned but also all the suppliers we use to go to market. Three: Speed issues: After the artwork change is agreed, there is a rush to go to market as soon as possible. Every day that passes without the product on the shelfs results in losses for the company. But working under huge pressure is when mistakes are more likely to happen. Four: Quality issues: Sometimes errors do not necessitate a recall, but they are still quality defects. Even though you don't have to start a recall, there can be potential quality control issues throughout the artwork process, and each of them have to be taken seriously. So, how to avoid these common pharma artwork hurdles? Pharma companies need to keep full control of their end-to-end artwork processes, making sure they are building quality into them. Reducing the risk of errors at every stage, ensuring they are 100% GMP compliant, and managing interactions and communications with stakeholders and suppliers are the key priorities. How to achieve that depends on the company, but one of the best ways today is through an Artwork Management System (AMS). Many of these are specifically designed for pharma companies to drive quality, security and GMP compliance while bringing better visibility to the full end-to-end artwork process. Top pharma companies are choosing GLAMS, (Global Artwork Management System), Perigord's pharma focused AMS, enables you to gain full control over your artwork processes, avoid hurdles, align with the industry regulations and thus improve your business results.
By Gary Orr 16 Jul, 2019
Perigord strives to be a responsible corporate citizen, wherever we do business. That means we are committed to conducting our business ethically, legally, and in a manner that is fiscally, environmentally, and socially responsible, while delivering sustainable value and strong financial performance. Our Corporate Responsibility Policy is built on the following areas of commitment that reflect existing and emerging benchmarks of Corporate Responsibility: Board Commitment Sustainable Value Creation Governance and Business Practices Human Rights Environment, Health and Safety Community Involvement Stakeholder Relations
Show More

Webinars


20 May, 2021
Join us and your industry peers for our latest Webinar "How the power of a connected AMS and automated proofreading solution will improve the efficiencies of your process and increase your speed to market" on-demand now where experts from Dr. Pfleger Arzneimittel GmbH, Perigord and Schlafender Hase will share their experience and demonstrate how having an AMS system with integrated digital comparison functionality will increase your speed to market, reduce the risk of product recall, and provide a full end-to-end audit trail of all approvals.
17 Dec, 2020
Perigord Life Science Solutions is delighted to announce we are joining Orphan Drug Consulting to bring you this latest Webinar, "Launching an RX Product in the EU – Fail to Prepare, Prepare to Fail," with our panel of speakers covering the different packaging and artwork requirements to launch a product in Europe, along with the key regulatory differences between the US and EU regulatory bodies, the launch process and more.
01 Oct, 2020
Join our subject matter experts on our latest webinar who will map out the packaging artwork and labelling journey from late stage 2 clinical trials to commercialisation and beyond. This webinar will chart a course through the complexities you will face as you prepare your product for the market. Reserve your seat:
Show More

Articles


By Adriana Medina 06 Nov, 2023
Whitepaper zur Auswahl eines strategischen Partners für die Auslagerung von Artwork und Labelling in der D‑A‑CH-Region Wertsteigerung und Risikominderung durch Auslagerung an ein Fachunternehmen – ein Whitepaper zu bewährten Verfahren
12 May, 2022
Advanced Artwork and Labelling Production Analytics White Paper Pharmaceutical Artwork Departments can accelerate business impact with Advanced Artwork and Labelling Production Analytics (AALPA)
11 May, 2022
Selecting a Strategic Outsourcing Artwork and Labelling Partner White Paper Enhancing Value and Mitigating Risk by Outsourcing to A Subject Matter Expert Organisation – A Best Practice White Paper
06 Oct, 2020
Due to COVID-19, auditing as we know it is changing. In-person audits are increasingly being replaced by remote audits. Read our guide to a successful remote audit.
By Gary Orr 16 Jul, 2019
Your company celebration and kudos does not last long as someone spots an artwork issue. In other words: here comes the recall. Yes, the worst-case scenario. We guess you won't sleep very well until this nightmare is over. If you are looking for fully compliant and error-free pharma artworks to hit the market efficiently while reducing your stress levels, keep an eye on the following four most common pharma artwork hurdles: One: Artwork process problems: Outdated and inefficient manual systems, systematic errors, inconsistencies, process gaps... all of them will develop into artwork errors. Too many assets, too many emails, too many people. Two: Compliance burdens: Labelling needs to be compliant with local regulations and current Good Manufacturing Practice, and this is probably the biggest concern for pharma companies. As these two become more and more complex over time, we need to ensure not only our company is fully aligned but also all the suppliers we use to go to market. Three: Speed issues: After the artwork change is agreed, there is a rush to go to market as soon as possible. Every day that passes without the product on the shelfs results in losses for the company. But working under huge pressure is when mistakes are more likely to happen. Four: Quality issues: Sometimes errors do not necessitate a recall, but they are still quality defects. Even though you don't have to start a recall, there can be potential quality control issues throughout the artwork process, and each of them have to be taken seriously. So, how to avoid these common pharma artwork hurdles? Pharma companies need to keep full control of their end-to-end artwork processes, making sure they are building quality into them. Reducing the risk of errors at every stage, ensuring they are 100% GMP compliant, and managing interactions and communications with stakeholders and suppliers are the key priorities. How to achieve that depends on the company, but one of the best ways today is through an Artwork Management System (AMS). Many of these are specifically designed for pharma companies to drive quality, security and GMP compliance while bringing better visibility to the full end-to-end artwork process. Top pharma companies are choosing GLAMS, (Global Artwork Management System), Perigord's pharma focused AMS, enables you to gain full control over your artwork processes, avoid hurdles, align with the industry regulations and thus improve your business results.
By Gary Orr 16 Jul, 2019
Perigord strives to be a responsible corporate citizen, wherever we do business. That means we are committed to conducting our business ethically, legally, and in a manner that is fiscally, environmentally, and socially responsible, while delivering sustainable value and strong financial performance. Our Corporate Responsibility Policy is built on the following areas of commitment that reflect existing and emerging benchmarks of Corporate Responsibility: Board Commitment Sustainable Value Creation Governance and Business Practices Human Rights Environment, Health and Safety Community Involvement Stakeholder Relations
Show More

Webinars


20 May, 2021
Join us and your industry peers for our latest Webinar "How the power of a connected AMS and automated proofreading solution will improve the efficiencies of your process and increase your speed to market" on-demand now where experts from Dr. Pfleger Arzneimittel GmbH, Perigord and Schlafender Hase will share their experience and demonstrate how having an AMS system with integrated digital comparison functionality will increase your speed to market, reduce the risk of product recall, and provide a full end-to-end audit trail of all approvals.
17 Dec, 2020
Perigord Life Science Solutions is delighted to announce we are joining Orphan Drug Consulting to bring you this latest Webinar, "Launching an RX Product in the EU – Fail to Prepare, Prepare to Fail," with our panel of speakers covering the different packaging and artwork requirements to launch a product in Europe, along with the key regulatory differences between the US and EU regulatory bodies, the launch process and more.
01 Oct, 2020
Join our subject matter experts on our latest webinar who will map out the packaging artwork and labelling journey from late stage 2 clinical trials to commercialisation and beyond. This webinar will chart a course through the complexities you will face as you prepare your product for the market. Reserve your seat:
Show More

An Essential Webinar Series for Pharma Professionals


Mind the Gap – Bridge the Packaging Divide Between R&D and Commercial Supply

On-demand access to our recent webinar that focuses on the journey to product launch where our panel of experts will ​provide you with a roadmap that will bridge the packaging gap between late stage 2 clinicals and commercialization.

On-Demand Access

Launching an RX product in the EU – FAIL to Prepare, Prepare to FAIL:

You can now access our latest EU product launch webinar on-demand! This webinar will help position you for success when launching an Rx product in the European Union and its 27 markets.

On-Demand Access

Launching an RX product in the US – FAIL to Prepare, Prepare to FAIL:

If you missed our US product launch webinar series, you can access these sessions on-demand where you will hear about the latest best practices you should be introducing into your business to ensure its products are brought to market on-time.

On-Demand Access
Share by: